3Cash JM.Methotrexate[J].Rheumatic disease Clinics of north America,1997,23(4):545.
4Porter DR,Capell.The use of sulphasalazine as a disease modifying antirheumatic drug[J].Baillieres Clin Rheumatol,1990,4(3):535～551.
5Haagsma CJ,Van Riel PL,de Rooij DJ,et al.Combination of methotrexate and sulphasalazine vs methotrexate alone:a randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapy[J].Br J Rheumatol,1994,33 (11):1049 ～ 1055.
6O'Dell JR,Leff R,Paulsen G,et al.Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine,methotrexate and sulfasalazine,or a combination of the three medications:results of a two-year,randomized,double-blind,placebo-controlled trial[J].Arthritis Rheum,2002,46(5):1164～1170.
7Hyrich KL,Symmons DP,Watson KD,et al.Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis:Results from the British Society for Rheumatology Biologics Register[J].Arthritis Rheum,2006,54(6):1786～1794.
